The present manuscript details structure-activity relationship studies of lead structure 1, which led to the discovery of CCR1 antagonists >100-fold more potent than 1. (C) 2004 Elsevier Ltd. All rights reserved.
The present manuscript details structure-activity relationship studies of lead structure 1, which led to the discovery of CCR1 antagonists >100-fold more potent than 1. (C) 2004 Elsevier Ltd. All rights reserved.